Media & Resources

Filter by

  • Type

  • Health area

  • Location

  • Topic

  • Year

  • Journal

  • Publication

  • Fact sheet & publication type

  • Clear all

Features

IAVI statement on PrEPVacc trial

December 6, 2023

Trial will stop vaccinations due to lack of efficacy.

Read more

Features

The moment is now: navigating the path to TB vaccine success at the Union Conference and beyond

December 6, 2023

This year’s Union Conference set the scene for what could be the biggest year to date for tuberculosis (TB) vaccines.

Read more

Features

This World AIDS Day, celebrating community leadership

December 1, 2023

“Science, when it is inclusive, becomes a powerful tool for change,” says IAVI’s Monica Kuteesa.

Read more

Features

IAVI and Partners Announce the 7th Global Forum on TB Vaccines in 2024 in Rio de Janeiro, Brazil

November 20, 2023

Global Forum on TB Vaccines will take place October 8-10, 2024 — the first time the meeting will be hosted in the Americas, coming at a time of renewed attention to TB vaccine research and development.

Read more

Features

Joint statement by FIND, IAVI, and TB Alliance at the UN High Level Meeting on TB

September 22, 2023

The following commitments must be prioritized by Heads of State and Governments to accelerate the development and delivery of the new tools that are urgently needed to end TB.

Read more

Features

Discovery of gene limiting replication of HIV published in Nature

August 2, 2023

New study of nearly 4,000 people of African ancestries led to identification of gene inhibiting HIV replication.

Read more

Features

Join IAVI at the 2023 International AIDS Conference!

July 17, 2023

Taking place in Brisbane, Australia, this International AIDS Society (IAS) conference features the latest scientific research for progress against the HIV epidemic.

Read more

Features

IAVI welcomes Germany to its list of generous supporters and recognizes the German government as a steadfast advocate and active participant in global health initiatives

July 6, 2023

Germany commits to 9.2 million Euros for the next five years to support development of a safe, effective, affordable, and accessible tuberculosis vaccine.

Read more